It mainly describes the mechanism of action of VGLUT1 expression changes in a series of central and peripheral nervous system diseases such as learning and memory disorders, Alzheimer’s disease and Parkinson’s disease et al. Here, SLC17A7 is linked to early-onset autosomal dominant Alzheimer disease.